SEC FORM 5 SEC Form 5
FORM 5 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0362
Estimated average burden
hours per response: 1.0
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Form 3 Holdings Reported.
Form 4 Transactions Reported.
1. Name and Address of Reporting Person*
IVERSEN PATRICK L

(Last) (First) (Middle)
ONE SW COLUMBIA, SUITE 1105

(Street)
PORTLAND OR 97258

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AVI BIOPHARMA INC [ AVII ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Sr VP of Research & Devlopment
3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/2007
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Amount (A) or (D) Price
Common Stock 05/15/2007 J 2,817(1) A $2.278 51,883 D
Common Stock 11/15/2007 J 2,875(1) A $2.261 54,758 D
Common Stock 3,000 I by Spouse
Common Stock 6,000 I by Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
(A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Incentive Stock Option (right to buy) $6.6875 09/01/2007 J 59,812 09/01/1997 09/01/2007(2) Common Stock 59,812 (2) 0 D
Non-Qualified Stock Option (right to buy) $6.6875 09/01/2007 J 40,188 09/01/1997 09/01/2007(2) Common Stock 40,188 (2) 0 D
Incentive Stock Option (right to buy) $2.53 02/22/2006(3) 02/22/2015 Common Stock 75,000 75,000 D
Incentive Stock Option (right to buy) $3 02/06/2009(3) 02/06/2017 Common Stock 33,334 33,334 D
Incentive Stock Option (right to buy) $3.6875 01/21/2000(4) 01/21/2009 Common Stock 14,000 14,000 D
Incentive Stock Option (right to buy) $5.35 12/05/2004(3) 12/05/2012 Common Stock 37,382 37,382 D
Incentive Stock Option (right to buy) $5.75 01/03/2001(3) 01/03/2010 Common Stock 25,960 25,960 D
Incentive Stock Option (right to buy) $7.35 02/16/2007(3) 02/16/2016 Common Stock 23,605 23,605 D
Non-Qualified Stock Option (right to buy) $3 02/06/2008(3) 02/06/2017 Common Stock 91,666 91,666 D
Non-Qualified Stock Option (right to buy) $3.6875 01/21/2000(4) 01/21/2009 Common Stock 14,000 14,000 D
Non-Qualified Stock Option (right to buy) $5.35 12/05/2003(3) 12/05/2012 Common Stock 55,018 55,018 D
Non-Qualified Stock Option (right to buy) $5.75 01/03/2001(3) 01/03/2010 Common Stock 58,040 58,040 D
Non-Qualified Stock Option (right to buy) $6.625 01/01/1999(5) 02/02/2008 Common Stock 56,000 56,000 D
Non-Qualified Stock Option (right to buy) $7.35 02/16/2007(3) 02/16/2016 Common Stock 51,395 51,395 D
Explanation of Responses:
1. This amount represents shares acquired through the company's ESPP program.
2. All shares expired.
3. The Stock Option Grant vest as follows: 1/3 vest one year from date of grant and 1/3 each year thereafter until all shares vest three years from grant date.
4. Vesting: 25% of the shares vest each year from the date of grant with all shares vesting in four years.
5. Option Grant vests 50% each year on grant date with all shares vesting two years from grant date.
By: Mark M. Webber, Attorney-in-fact For: Patrick L. Iversen 02/14/2008
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.